Microchip Biotechnologies Licenses Technology for Developing Microfluidic Devices
Complete the form below to unlock access to ALL audio articles.
Microchip Biotechnologies, Inc. (MBI) and TEC Edmonton have entered into an exclusive patent license agreement that allows MBI to commercialize a University of Alberta invention that can improve the development of lab-on-a-chip devices and biosampling procedures.
“The licensing of this fundamental patent on manipulating beads on-chip continues to build upon our strong intellectual property position in microfluidic devices,” said Stevan Jovanovich, President and CEO of MBI.
“Microfluidic devices will play a critical role in next generation instrumentation in delivering fully automated, cost effective solutions life science, applied sciences, and diagnostic products for laboratory and field based applications,” he added.
California-based MBI will use the technology patented by TEC Edmonton officially called an Apparatus and Method for Trapping Bead Based Reagents within Microfluidic Analysis Systems (US Patent 6,432,290).
A team led by Dr. Jed Harrison, Professor and Chair in the Department of Chemistry, invented the technology to allow trapping of beads on-chip, as well as packing and unpacking the trapping zones, which significantly extends the applications of microfluidic analysis systems, such as those used in biodefense and genomics industries.
